Generating key takeaways...
Shoppers are noticing health plans trying to make prior authorisation less painful. Evry Health, a Dallas-based insurer, is using an AI tool to slash denial rates and cut the time clinicians spend on paperwork, a practical look at why faster, smarter approvals matter for doctors, patients and busy practices.
Essential Takeaways
- Big pledge: More than 50 insurers joined an AHIP initiative to reduce prior authorisations and move to real‑time electronic approvals by 2027.
- Evry’s results: The company cut denial rates from 7% in 2024 to 4% by the end of 2025, using its AI system.
- Speed boost: Manual reviews that once took about 30 minutes are being compressed to roughly five minutes with automation.
- Doc-friendly approach: Evry fixes paperwork errors and coaches practices instead of issuing outright denials, keeping relationships intact.
- Practical reality: Smaller practices still use faxes and handwritten forms, so pragmatic tech that tolerates messy inputs matters.
Why prior authorisation has become a national priority
Prior authorisation is the paperwork bog many doctors and patients dread, and industry trade group America’s Health Insurance Plans has pushed insurers to do something about it. The AHIP pledge targets an 11 percent reduction in procedures needing prior authorisation and a shift toward rapid digital approvals by 2027. That’s not just bureaucracy-speak , it’s a response to long waits, frustrated clinicians and patients delaying care.
Insurers and medical groups alike have felt the pain; the process can take hours of staff time and lead to missed appointments. So the move to streamline approvals is both a cost and care play: faster decisions mean clinicians can focus on patients, not forms.
How Evry’s AI cuts the grunt work and speeds decisions
Evry Health built an AI platform called Authoritative that automates the background document work , pulling together records, linking data to the patient file and checking evidence-based guidelines. The upshot: what used to need a 30-minute review can become a medical determination in about five minutes.
According to Evry’s CEO, the system acts as a decision‑support tool rather than a hard gatekeeper. That means clinicians still make the judgement calls, but the software does the heavy lifting, giving staff a less repetitive, more rewarding job.
Denials down, but does approval mean more care?
Cutting denials sounds good, but critics often worry faster approvals could mean unnecessary care and higher costs. Evry argues its member base is relatively healthy and that many members don’t use care often; their priority is catching small issues early so they don’t become major problems.
The company hasn’t proved a direct link between faster approvals and better long‑term outcomes yet, which matters for policymakers and employers watching costs. Still, a lower denial rate paired with tighter evidence checks suggests the aim is better care navigation rather than blanket acceptance.
Building technology around how doctors actually work
Evry’s practical twist is worth noting: rather than forcing every practice to upgrade to flawless API integrations, the company trained models to read badly photocopied faxes and messy handwritten forms. That’s a real-world concession , many small practices still rely on paper and fax machines , and it means the tech meets clinicians where they are.
For larger health systems with in-house engineering, API integration is viable and often preferred. But for independent GPs and small clinics, AI that tolerates imperfect inputs is a faster win. Evry’s approach reduces the unfair burden on smaller providers and keeps patient access front and centre.
Collaboration beats confrontation: why communication matters
Evry doesn’t just automate; it communicates. When paperwork is wrong, staff correct the form, tell the practice what happened and explain how to submit properly next time. That collaborative stance turns insurers and providers into partners, not adversaries, and eases friction for patients caught in the middle.
Industrywide, most signatories to the AHIP pledge are focusing first on turnaround times and API connections. Evry’s experience suggests there’s room for mixed strategies: invest in integration where possible, and build tolerant, pragmatic tools where systems are still analogue.
It’s a small change that can make every approval faster and less painful.
Source Reference Map
Story idea inspired by: [1]
Sources by paragraph:
Noah Fact Check Pro
The draft above was created using the information available at the time the story first
emerged. We’ve since applied our fact-checking process to the final narrative, based on the criteria listed
below. The results are intended to help you assess the credibility of the piece and highlight any areas that may
warrant further investigation.
Freshness check
Score:
10
Notes:
The article was published on May 4, 2026, and presents recent developments regarding Evry Health’s AI-driven prior authorization system, with no evidence of prior publication or recycled content.
Quotes check
Score:
10
Notes:
Direct quotes from Chris Gay, CEO of Evry Health, are unique to this article, with no prior instances found online, indicating originality.
Source reliability
Score:
8
Notes:
D CEO Magazine is a reputable publication covering business and healthcare topics in Dallas. However, as a regional magazine, it may have limited reach and influence compared to national outlets.
Plausibility check
Score:
9
Notes:
The claims about Evry Health’s AI system reducing prior authorization denial rates from 7% in 2024 to 4% by the end of 2025 are plausible and align with industry trends. However, the article lacks independent verification from external sources to fully substantiate these claims.
Overall assessment
Verdict (FAIL, OPEN, PASS): PASS
Confidence (LOW, MEDIUM, HIGH): MEDIUM
Summary:
The article presents recent developments regarding Evry Health’s AI-driven prior authorization system, with unique quotes and no evidence of recycled content. However, the reliance on statements from Evry Health’s CEO and D CEO Magazine’s reporting without independent verification from external sources raises concerns about potential bias and the need for further corroboration. Given these factors, the content passes the verification check with medium confidence.
